| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.10e-07 | 102 | 75 | 7 | GO:0005249 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.74e-07 | 334 | 75 | 10 | GO:0022836 | |
| GeneOntologyMolecularFunction | beta-galactosidase activity | 5.06e-07 | 5 | 75 | 3 | GO:0004565 | |
| GeneOntologyMolecularFunction | potassium channel activity | 5.21e-07 | 128 | 75 | 7 | GO:0005267 | |
| GeneOntologyMolecularFunction | channel activity | ANO4 GJA3 KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 ANO5 PKD1L2 | 5.58e-07 | 525 | 75 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ANO4 GJA3 KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 ANO5 PKD1L2 | 5.69e-07 | 526 | 75 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANO4 KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 ANO5 PKD1L2 | 1.09e-06 | 459 | 75 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.66e-06 | 152 | 75 | 7 | GO:0022843 | |
| GeneOntologyMolecularFunction | galactosidase activity | 1.76e-06 | 7 | 75 | 3 | GO:0015925 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 2.45e-06 | 103 | 75 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.11e-06 | 167 | 75 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.43e-06 | 343 | 75 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 5.48e-06 | 182 | 75 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.89e-06 | 184 | 75 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 SLC34A3 PKD1L2 | 9.12e-06 | 465 | 75 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.69e-05 | 144 | 75 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO4 KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 ANO5 SLC34A3 PKD1L2 | 2.38e-05 | 758 | 75 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO4 KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 ANO5 SLC34A3 PKD1L2 | 3.71e-05 | 793 | 75 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 8.73e-05 | 193 | 75 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 9.77e-05 | 197 | 75 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 SLC34A3 PKD1L2 | 1.14e-04 | 627 | 75 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 1.56e-04 | 28 | 75 | 3 | GO:0005242 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 SLC34A3 PKD1L2 | 1.82e-04 | 664 | 75 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | ANO4 GJA3 KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 NPC1L1 KCNK1 KCNQ2 KCNQ3 ANO5 SLC34A3 PKD1L2 | 2.78e-04 | 1289 | 75 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO4 GJA3 KCNQ5 ASIC2 KCNQ4 KCNH2 KCNJ3 KCNK1 KCNQ2 KCNQ3 ANO5 SLC34A3 PKD1L2 | 4.13e-04 | 1180 | 75 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization | 8.97e-04 | 12 | 75 | 2 | GO:1902282 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization | 1.42e-03 | 15 | 75 | 2 | GO:0086008 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 1.83e-03 | 17 | 75 | 2 | GO:0072542 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.83e-03 | 17 | 75 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.91e-03 | 140 | 75 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 2.53e-03 | 20 | 75 | 2 | GO:0019211 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 2.53e-03 | 20 | 75 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 2.53e-03 | 20 | 75 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.64e-03 | 153 | 75 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 3.35e-03 | 23 | 75 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.57e-03 | 288 | 75 | 5 | GO:0016757 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO4 KCNQ5 TMEM168 ASIC2 KCNQ4 KCNH2 KCNJ3 HECW2 KCNK1 KCNQ2 KCNQ3 ANO5 SLC34A3 PKD1L2 | 7.96e-06 | 1017 | 71 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 1.50e-05 | 232 | 71 | 7 | GO:0071805 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO4 KCNQ5 TMEM168 ASIC2 KCNQ4 KCNH2 KCNJ3 HECW2 KCNK1 KCNQ2 KCNQ3 ANO5 SLC34A3 PKD1L2 | 2.24e-05 | 1115 | 71 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of action potential firing threshold | 3.50e-05 | 3 | 71 | 2 | GO:0099611 | |
| GeneOntologyBiologicalProcess | substantia propria of cornea development | 3.50e-05 | 3 | 71 | 2 | GO:1903701 | |
| GeneOntologyBiologicalProcess | apoptosome assembly | 3.50e-05 | 3 | 71 | 2 | GO:0097314 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 4.16e-05 | 272 | 71 | 7 | GO:0006813 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | KCNQ5 TMEM168 ASIC2 KCNQ4 KCNH2 KCNJ3 HECW2 KCNK1 KCNQ2 KCNQ3 SLC34A3 PKD1L2 | 6.65e-05 | 922 | 71 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | MAN2B2 GLB1L3 GLB1L HYAL3 GYS2 EXT2 GLB1L2 POFUT2 MYORG CHST3 | 6.99e-05 | 646 | 71 | 10 | GO:0005975 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 8.12e-05 | 208 | 71 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | KCNQ5 TMEM168 ASIC2 KCNQ4 KCNH2 KCNJ3 HECW2 KCNK1 KCNQ2 KCNQ3 SLC34A3 PKD1L2 | 8.16e-05 | 942 | 71 | 12 | GO:0098655 |
| GeneOntologyBiologicalProcess | action potential initiation | 1.16e-04 | 5 | 71 | 2 | GO:0099610 | |
| GeneOntologyBiologicalProcess | metal ion transport | KCNQ5 TMEM168 ASIC2 KCNQ4 KCNH2 KCNJ3 HECW2 KCNK1 KCNQ2 KCNQ3 SLC34A3 PKD1L2 | 1.43e-04 | 1000 | 71 | 12 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO4 KCNQ5 TMEM168 ASIC2 KCNQ4 KCNH2 KCNJ3 HECW2 KCNK1 KCNQ2 KCNQ3 ANO5 SLC34A3 PKD1L2 | 2.11e-04 | 1374 | 71 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | inhibitory chemical synaptic transmission | 2.43e-04 | 7 | 71 | 2 | GO:0098977 | |
| GeneOntologyBiologicalProcess | psychomotor behavior | 2.43e-04 | 7 | 71 | 2 | GO:0036343 | |
| GeneOntologyBiologicalProcess | exocyst localization | 3.23e-04 | 8 | 71 | 2 | GO:0051601 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotrophin TRK receptor signaling pathway | 3.23e-04 | 8 | 71 | 2 | GO:0051388 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.69e-04 | 275 | 71 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | KCNQ5 TMEM168 ASIC2 KCNQ4 KCNH2 KCNJ3 HECW2 KCNK1 KCNQ2 KCNQ3 SLC34A3 PKD1L2 | 5.44e-04 | 1157 | 71 | 12 | GO:0006812 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 6.04e-04 | 198 | 71 | 5 | GO:0007605 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 3.33e-08 | 91 | 74 | 7 | GO:0008076 | |
| GeneOntologyCellularComponent | potassium channel complex | 8.42e-08 | 104 | 74 | 7 | GO:0034705 | |
| GeneOntologyCellularComponent | inward rectifier potassium channel complex | 1.70e-07 | 4 | 74 | 3 | GO:1902937 | |
| GeneOntologyCellularComponent | cation channel complex | 1.97e-05 | 235 | 74 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.80e-04 | 378 | 74 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 4.30e-04 | 785 | 74 | 10 | GO:0098797 | |
| HumanPheno | Facial cyanosis | 3.35e-05 | 2 | 30 | 2 | HP:0034031 | |
| HumanPheno | Circumoral cyanosis | 3.35e-05 | 2 | 30 | 2 | HP:0032556 | |
| Domain | K_chnl_volt-dep_KCNQ | 1.07e-09 | 5 | 73 | 4 | IPR003937 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 1.07e-09 | 5 | 73 | 4 | IPR013821 | |
| Domain | KCNQ_channel | 1.07e-09 | 5 | 73 | 4 | PF03520 | |
| Domain | Glyco_hydro_35 | 2.29e-07 | 4 | 73 | 3 | PF01301 | |
| Domain | Gly_Hdrlase_35_cat | 2.29e-07 | 4 | 73 | 3 | IPR031330 | |
| Domain | Glycoside_Hdrlase_35 | 2.29e-07 | 4 | 73 | 3 | IPR001944 | |
| Domain | B-gal_1-like | 2.29e-07 | 4 | 73 | 3 | IPR026283 | |
| Domain | GLYCOSYL_HYDROL_F35 | 2.29e-07 | 4 | 73 | 3 | PS01182 | |
| Domain | Glycoside_hydrolase_SF | 1.97e-06 | 53 | 73 | 5 | IPR017853 | |
| Domain | VG_K_chnl | 8.07e-06 | 33 | 73 | 4 | IPR028325 | |
| Domain | KCNQC3-Ank-G_bd | 1.51e-05 | 2 | 73 | 2 | PF11956 | |
| Domain | K_chnl_volt-dep_KCNQ2 | 1.51e-05 | 2 | 73 | 2 | IPR003947 | |
| Domain | Ankyrin-G_BS | 1.51e-05 | 2 | 73 | 2 | IPR020969 | |
| Domain | Ion_trans_dom | 8.37e-05 | 114 | 73 | 5 | IPR005821 | |
| Domain | Ion_trans | 8.37e-05 | 114 | 73 | 5 | PF00520 | |
| Domain | PP2A_B56 | 1.50e-04 | 5 | 73 | 2 | IPR002554 | |
| Domain | B56 | 1.50e-04 | 5 | 73 | 2 | PF01603 | |
| Domain | Glyco_transf_64 | 1.50e-04 | 5 | 73 | 2 | PF09258 | |
| Domain | Exostosin | 1.50e-04 | 5 | 73 | 2 | IPR004263 | |
| Domain | EXT_C | 1.50e-04 | 5 | 73 | 2 | IPR015338 | |
| Domain | Exostosin | 1.50e-04 | 5 | 73 | 2 | PF03016 | |
| Domain | Anoct_dimer | 3.12e-04 | 7 | 73 | 2 | PF16178 | |
| Domain | Anoct_dimer | 3.12e-04 | 7 | 73 | 2 | IPR032394 | |
| Domain | - | 3.43e-04 | 35 | 73 | 3 | 3.20.20.80 | |
| Domain | Glyco_hydro_catalytic_dom | 4.38e-04 | 38 | 73 | 3 | IPR013781 | |
| Domain | Anoctamin | 6.64e-04 | 10 | 73 | 2 | PF04547 | |
| Domain | Anoctamin | 6.64e-04 | 10 | 73 | 2 | IPR007632 | |
| Domain | - | 2.93e-03 | 73 | 73 | 3 | 2.60.120.260 | |
| Domain | - | 3.93e-03 | 81 | 73 | 3 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 4.96e-03 | 88 | 73 | 3 | IPR029044 | |
| Domain | Galactose-bd-like | 5.95e-03 | 94 | 73 | 3 | IPR008979 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 1.21e-07 | 103 | 54 | 7 | M1073 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 2.54e-07 | 15 | 54 | 4 | M22002 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 5.88e-07 | 43 | 54 | 5 | M1056 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.30e-06 | 288 | 54 | 9 | M16864 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 7.16e-06 | 123 | 54 | 6 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 8.23e-06 | 126 | 54 | 6 | M695 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 2.34e-05 | 15 | 54 | 3 | M691 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 2.34e-05 | 15 | 54 | 3 | MM14799 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 3.54e-05 | 98 | 54 | 5 | MM14545 | |
| Pathway | WP_PROTEOGLYCAN_BIOSYNTHESIS | 4.16e-05 | 18 | 54 | 3 | M39865 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 5.28e-05 | 54 | 54 | 4 | MM14633 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 6.53e-05 | 57 | 54 | 4 | M692 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 7.35e-05 | 271 | 54 | 7 | MM15406 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 8.91e-05 | 23 | 54 | 3 | MM14804 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 1.02e-04 | 24 | 54 | 3 | M636 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 2.92e-04 | 34 | 54 | 3 | MM17076 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 2.92e-04 | 34 | 54 | 3 | MM15985 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 3.47e-04 | 36 | 54 | 3 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 3.47e-04 | 36 | 54 | 3 | MM14632 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 4.40e-04 | 39 | 54 | 3 | M48042 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 4.75e-04 | 40 | 54 | 3 | M39595 | |
| Pathway | WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS | 5.10e-04 | 9 | 54 | 2 | M48307 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 5.11e-04 | 41 | 54 | 3 | M48095 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 5.11e-04 | 41 | 54 | 3 | MM14546 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 7.75e-04 | 11 | 54 | 2 | M47921 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 9.24e-04 | 411 | 54 | 7 | M735 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 1.09e-03 | 53 | 54 | 3 | MM14647 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 1.09e-03 | 13 | 54 | 2 | M46426 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 1.41e-03 | 58 | 54 | 3 | M576 | |
| Pathway | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS | 1.46e-03 | 15 | 54 | 2 | M27407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE | 1.67e-03 | 16 | 54 | 2 | M47870 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.89e-03 | 17 | 54 | 2 | MM15096 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 1.89e-03 | 17 | 54 | 2 | M27083 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.89e-03 | 17 | 54 | 2 | M919 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 2.12e-03 | 18 | 54 | 2 | MM14759 | |
| Pathway | WP_KCNQ2RELATED_EPILEPSIES | 2.36e-03 | 19 | 54 | 2 | M48320 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 2.36e-03 | 19 | 54 | 2 | M47525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 2.62e-03 | 20 | 54 | 2 | M47876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.89e-03 | 21 | 54 | 2 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.89e-03 | 21 | 54 | 2 | MM14996 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 3.17e-03 | 22 | 54 | 2 | M47919 | |
| Pubmed | The contribution of Kv7 channels to pregnant mouse and human myometrial contractility. | 9.95e-11 | 5 | 75 | 4 | 20132415 | |
| Pubmed | Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase. | 9.95e-11 | 5 | 75 | 4 | 15304482 | |
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 26969140 | ||
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 12890507 | ||
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 18786918 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.21e-08 | 139 | 75 | 7 | 16985003 | |
| Pubmed | 2.53e-08 | 40 | 75 | 5 | 16382104 | ||
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 10713961 | ||
| Pubmed | A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly. | 3.85e-08 | 4 | 75 | 3 | 12524525 | |
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 12032157 | ||
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 21730298 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 15608631 | ||
| Pubmed | Benign neonatal sleep myoclonus: an autosomal dominant form not allelic to KCNQ2 or KCNQ3. | 4.59e-06 | 2 | 75 | 2 | 22447848 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 16319223 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 19453707 | ||
| Pubmed | Pathogenic plasticity of Kv7.2/3 channel activity is essential for the induction of tinnitus. | 4.59e-06 | 2 | 75 | 2 | 23716673 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 18166285 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10025409 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 23650395 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 32580997 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 18483067 | ||
| Pubmed | Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. | 4.59e-06 | 2 | 75 | 2 | 9872318 | |
| Pubmed | KCNQ channels show conserved ethanol block and function in ethanol behaviour. | 4.59e-06 | 2 | 75 | 2 | 23209695 | |
| Pubmed | KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. | 4.59e-06 | 2 | 75 | 2 | 9836639 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 38049972 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 24843134 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10684873 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 25740509 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 23002961 | ||
| Pubmed | Expression and localization of K channels KCNQ2 and KCNQ3 in the mammalian cochlea. | 4.59e-06 | 2 | 75 | 2 | 18827480 | |
| Pubmed | Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents. | 4.59e-06 | 2 | 75 | 2 | 18536747 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 16235065 | ||
| Pubmed | Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. | 4.59e-06 | 2 | 75 | 2 | 10953053 | |
| Pubmed | Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells. | 4.59e-06 | 2 | 75 | 2 | 11159685 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 16721610 | ||
| Pubmed | Rapid chemically induced changes of PtdIns(4,5)P2 gate KCNQ ion channels. | 4.59e-06 | 2 | 75 | 2 | 16990515 | |
| Pubmed | Novel role of KCNQ2/3 channels in regulating neuronal cell viability. | 4.59e-06 | 2 | 75 | 2 | 20885443 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10713399 | ||
| Pubmed | Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. | 4.59e-06 | 2 | 75 | 2 | 10908292 | |
| Pubmed | KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3. | 4.59e-06 | 2 | 75 | 2 | 35320039 | |
| Pubmed | The Kv7.2/Kv7.3 heterotetramer assembles with a random subunit arrangement. | 4.59e-06 | 2 | 75 | 2 | 22334706 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 24333508 | ||
| Pubmed | Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation. | 4.59e-06 | 2 | 75 | 2 | 15483133 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 12832524 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 12640002 | ||
| Pubmed | Direct neurotransmitter activation of voltage-gated potassium channels. | 4.59e-06 | 2 | 75 | 2 | 29748663 | |
| Pubmed | KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. | 4.59e-06 | 2 | 75 | 2 | 18625963 | |
| Pubmed | KCNQ Potassium Channels Modulate Sensitivity of Skin Down-hair (D-hair) Mechanoreceptors. | 4.59e-06 | 2 | 75 | 2 | 26733196 | |
| Pubmed | Inactivation as a new regulatory mechanism for neuronal Kv7 channels. | 4.59e-06 | 2 | 75 | 2 | 17237198 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 18089837 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 19389803 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 31871302 | ||
| Pubmed | Vestibular role of KCNQ4 and KCNQ5 K+ channels revealed by mouse models. | 4.59e-06 | 2 | 75 | 2 | 23408425 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 14534157 | ||
| Pubmed | Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. | 4.59e-06 | 2 | 75 | 2 | 10854243 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 27607834 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 26627826 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 37607817 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 29474891 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10479678 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 20437616 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 9677360 | ||
| Pubmed | Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents. | 4.59e-06 | 2 | 75 | 2 | 19060215 | |
| Pubmed | DNA methylation and expression of KCNQ3 in bipolar disorder. | 4.59e-06 | 2 | 75 | 2 | 25041603 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10788442 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 21466805 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ERGIC1 GXYLT2 MAN2B2 BRI3BP HYAL3 EXT2 EXTL3 GLB1L2 POFUT2 MYORG DMXL1 CHST3 | 9.55e-06 | 1201 | 75 | 12 | 35696571 |
| Pubmed | SMIT1 Modifies KCNQ Channel Function and Pharmacology by Physical Interaction with the Pore. | 1.37e-05 | 3 | 75 | 2 | 28793216 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 24375629 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 12458027 | ||
| Pubmed | Structural Insights into the M-Channel Proximal C-Terminus/Calmodulin Complex. | 1.37e-05 | 3 | 75 | 2 | 27564677 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 30885609 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 34509475 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 26312501 | ||
| Pubmed | Sodium and potassium channel dysfunctions in rare and common idiopathic epilepsy syndromes. | 1.37e-05 | 3 | 75 | 2 | 19464834 | |
| Pubmed | Kv7 channels can function without constitutive calmodulin tethering. | 1.37e-05 | 3 | 75 | 2 | 21980481 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 14762142 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 24297175 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 24719109 | ||
| Pubmed | M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit. | 1.37e-05 | 3 | 75 | 2 | 11034315 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 21976501 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 17519950 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 25972378 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBC1D16 CTC1 KCNH2 KMT5C KCNQ2 TWNK EXTL3 MBD5 RALGAPA2 MYORG WDR24 | 2.42e-05 | 1105 | 75 | 11 | 35748872 |
| Pubmed | Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. | 2.75e-05 | 4 | 75 | 2 | 17761672 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 23360469 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 20592205 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 16525039 | ||
| Pubmed | Cloning and functional expression of a novel cardiac two-pore background K+ channel (cTBAK-1). | 2.75e-05 | 4 | 75 | 2 | 9506712 | |
| Pubmed | Chromosomal mapping of the potassium channel genes Kcnq2 and Kcnq3 in mouse. | 2.75e-05 | 4 | 75 | 2 | 10087209 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 23259949 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 15095873 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 28464250 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 8812429 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 10639137 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 25998125 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 10781098 | ||
| Pubmed | Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels. | 6.84e-05 | 6 | 75 | 2 | 12223552 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 27445338 | ||
| Pubmed | Identification and characterization of TMEM16E and TMEM16F genes in silico. | 6.84e-05 | 6 | 75 | 2 | 15067359 | |
| Interaction | KCNQ3 interactions | 1.68e-06 | 24 | 74 | 4 | int:KCNQ3 | |
| Interaction | KCNS1 interactions | 5.60e-06 | 10 | 74 | 3 | int:KCNS1 | |
| Interaction | FAM43A interactions | 9.02e-06 | 36 | 74 | 4 | int:FAM43A | |
| GeneFamily | Potassium voltage-gated channels | 6.53e-08 | 40 | 48 | 5 | 274 | |
| GeneFamily | Exostosin glycosyltransferase family | 6.87e-05 | 5 | 48 | 2 | 431 | |
| GeneFamily | Anoctamins | 3.06e-04 | 10 | 48 | 2 | 865 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 7.09e-04 | 15 | 48 | 2 | 696 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.43e-05 | 185 | 74 | 5 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.43e-05 | 185 | 74 | 5 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-05 | 188 | 74 | 5 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-05 | 198 | 74 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-05 | 198 | 74 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-05 | 198 | 74 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 74 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| Drug | Thallium | 5.79e-11 | 22 | 72 | 6 | ctd:D013793 | |
| Drug | Quinazolinones | 4.58e-10 | 5 | 72 | 4 | ctd:D052999 | |
| Drug | N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide | 1.37e-09 | 6 | 72 | 4 | ctd:C476437 | |
| Drug | isovaleramide | 6.37e-09 | 8 | 72 | 4 | CID000010930 | |
| Drug | valrocemide | 6.37e-09 | 8 | 72 | 4 | CID006918293 | |
| Drug | eslicarbazepine acetate | 6.37e-09 | 8 | 72 | 4 | CID000179344 | |
| Drug | CCD 1042 | 1.39e-08 | 25 | 72 | 5 | CID000038022 | |
| Drug | E 4031 | 1.85e-08 | 54 | 72 | 6 | CID000003184 | |
| Drug | ezogabine | 3.03e-08 | 3 | 72 | 3 | ctd:C101866 | |
| Drug | XE991 | 6.08e-08 | 33 | 72 | 5 | CID000656732 | |
| Drug | BMS-204352 | 6.43e-08 | 13 | 72 | 4 | CID000214350 | |
| Drug | benzanilide | 1.63e-07 | 16 | 72 | 4 | CID000007168 | |
| Drug | carisbamate | 1.63e-07 | 16 | 72 | 4 | CID006918474 | |
| Drug | linopirdine | 2.41e-07 | 43 | 72 | 5 | CID000003932 | |
| Drug | Pro-val | 3.80e-07 | 47 | 72 | 5 | CID000142984 | |
| Drug | AC1Q646P | 3.80e-07 | 47 | 72 | 5 | CID000005673 | |
| Drug | retigabine | 4.23e-07 | 48 | 72 | 5 | CID000121892 | |
| Drug | rufinamide | 2.06e-06 | 29 | 72 | 4 | CID000129228 | |
| Drug | valnoctamide | 2.71e-06 | 31 | 72 | 4 | CID000020140 | |
| Drug | niflumic acid | 2.82e-06 | 125 | 72 | 6 | CID000004488 | |
| Drug | sotalol | 3.49e-06 | 73 | 72 | 5 | CID000005253 | |
| Drug | diazoxide | 7.59e-06 | 227 | 72 | 7 | CID000003019 | |
| Drug | tetraethylammonium | 9.77e-06 | 236 | 72 | 7 | CID000005413 | |
| Drug | LY 300164 | 1.03e-05 | 43 | 72 | 4 | CID000126756 | |
| Drug | 4-AP | 1.74e-05 | 258 | 72 | 7 | CID000001727 | |
| Drug | lacosamide | 2.22e-05 | 52 | 72 | 4 | CID000219078 | |
| Drug | glibenclamide | 2.74e-05 | 382 | 72 | 8 | CID000003488 | |
| Drug | linopirdine | 2.95e-05 | 3 | 72 | 2 | ctd:C061017 | |
| Drug | (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide | 2.95e-05 | 3 | 72 | 2 | ctd:C576869 | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.67e-05 | 196 | 72 | 6 | 5741_DN | |
| Drug | AC1L9NAZ | 3.89e-05 | 198 | 72 | 6 | CID000449606 | |
| Drug | 1-chloro-1,2,2-trifluorocyclobutane | 5.85e-05 | 24 | 72 | 3 | CID000079091 | |
| Drug | Quinidine | 5.89e-05 | 4 | 72 | 2 | DB00908 | |
| Drug | 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone | 5.89e-05 | 4 | 72 | 2 | ctd:C112297 | |
| Drug | GDP-Man | 8.22e-05 | 140 | 72 | 5 | CID000000732 | |
| Drug | clofilium | 8.95e-05 | 74 | 72 | 4 | CID000002798 | |
| Drug | barium | 1.07e-04 | 148 | 72 | 5 | CID000104810 | |
| Drug | acotiamide | 2.18e-04 | 37 | 72 | 3 | CID005282338 | |
| Disease | long QT syndrome (implicated_via_orthology) | 2.01e-11 | 10 | 73 | 5 | DOID:2843 (implicated_via_orthology) | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.60e-10 | 32 | 73 | 6 | DOID:10273 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 2.42e-08 | 13 | 73 | 4 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Benign neonatal seizures | 6.04e-06 | 2 | 73 | 2 | cv:C0220669 | |
| Disease | benign neonatal seizures (implicated_via_orthology) | 6.04e-06 | 2 | 73 | 2 | DOID:14264 (implicated_via_orthology) | |
| Disease | benign neonatal seizures (is_implicated_in) | 1.81e-05 | 3 | 73 | 2 | DOID:14264 (is_implicated_in) | |
| Disease | hereditary multiple exostoses (implicated_via_orthology) | 3.61e-05 | 4 | 73 | 2 | DOID:206 (implicated_via_orthology) | |
| Disease | Familial benign neonatal epilepsy | 9.00e-05 | 6 | 73 | 2 | C0220669 | |
| Disease | 4-acetamidobutanoate measurement | 7.08e-04 | 16 | 73 | 2 | EFO_0021003 | |
| Disease | Disproportionate short stature | 9.32e-04 | 77 | 73 | 3 | C0878659 | |
| Disease | Brain Diseases | 1.75e-03 | 25 | 73 | 2 | C0006111 | |
| Disease | intestinal permeability measurement | 1.89e-03 | 26 | 73 | 2 | EFO_0011031 | |
| Disease | Encephalopathies | 2.04e-03 | 27 | 73 | 2 | C0085584 | |
| Disease | QT interval | 2.09e-03 | 534 | 73 | 6 | EFO_0004682 | |
| Disease | 1,5 anhydroglucitol measurement | 2.35e-03 | 29 | 73 | 2 | EFO_0008009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SWPHLQLVYEFFLRF | 161 | Q15173 | |
| FPAWEVYLRAFHSAV | 306 | Q17RC7 | |
| GRTYFVKIHAPWEVL | 126 | Q75V66 | |
| HVVFGRFFWIVRVVL | 151 | Q8WY22 | |
| RWFEFLHPGQVYRLI | 806 | Q2NKJ3 | |
| QVHFGRWLIEGSPYV | 101 | P54840 | |
| AWPHLQLVYEFFLRF | 206 | Q14738 | |
| WHPRIVAALVGFLYD | 386 | Q96C12 | |
| IFVKLHAPWEVLGRY | 161 | Q32M45 | |
| WLGLYRRFFKSPHFD | 481 | Q8NEG7 | |
| VYLAHPRAVNGFSWR | 226 | Q9Y485 | |
| LWPGRVGRHSLYFNV | 96 | Q8WXS8 | |
| HIFVYGPLTIRRVLW | 31 | Q16515 | |
| WYGLREFVVIAPAAH | 121 | Q15042 | |
| HFGVVTARYRWVAGV | 476 | Q8N130 | |
| PNWEARIDSHGRIFY | 811 | Q9P2P5 | |
| RYEFLWGPRAHSEVI | 1066 | O60732 | |
| HWARRYGLPYVVRVD | 391 | Q86Y97 | |
| GGSIHYFRVPREYWR | 91 | Q8NCI6 | |
| RSPWFILVGRAFVYL | 966 | O60333 | |
| TRRPVLYFHIRWGFS | 161 | O00180 | |
| ERPRGWALLYHALVF | 116 | O43525 | |
| RPRGWAFIYHAFVFL | 121 | Q9NR82 | |
| PGRIAVHYFKGWFLI | 486 | Q12809 | |
| LERPRGWAFVYHVFI | 91 | P56696 | |
| RYVPFDAAVDFHRWI | 1116 | Q9NRD8 | |
| PLFRELWRYHFATGV | 126 | Q6PID8 | |
| ERPRGWAFIYHAYVF | 86 | O43526 | |
| HTGRIIPAIWFRYDL | 221 | Q969X5 | |
| IPKIGWYSRFARHPF | 246 | A0PJZ3 | |
| PYLEQFRRIVFWLGD | 296 | Q96RR1 | |
| YQFACGGWLRRHVIP | 116 | Q495T6 | |
| LPERIFFRWHYQSIG | 96 | Q2PPJ7 | |
| RWTFEEGIKRPYFHV | 331 | Q86UA1 | |
| VSVHRPGFYAEWFQR | 376 | A2A3N6 | |
| GWHPFVVAAELIYFL | 2181 | Q7Z442 | |
| VYETPDRLWDLGRHF | 571 | Q8NFY9 | |
| YAPFLLHWITRGVVL | 836 | Q9UHC9 | |
| HLGRAAYIQPWRFRV | 61 | Q8IYK2 | |
| GTPWEFHAQRGYRVV | 301 | A8MY62 | |
| AFILCWLPFHVGRYL | 271 | Q92847 | |
| DRIVGFPGRYHAWDI | 766 | O43909 | |
| RVAQALRPHGLWGFY | 186 | O43820 | |
| GSLHYFRVPRVLWAD | 51 | Q6UWU2 | |
| DARLPKVFAWVYRHE | 146 | Q8N2R8 | |
| IIHEGPSVYRIFKRW | 291 | Q9P2E8 | |
| LYETFGIRPQFSWHV | 136 | Q9Y2E5 | |
| IHYRPRTFNVGDLVW | 1376 | Q9P267 | |
| AGLLFVVTRYLHSWP | 271 | Q8NFN8 | |
| GSIHYFRVPREYWRD | 66 | Q8IW92 | |
| LHERYGPVVSFWFGR | 61 | Q6UW02 | |
| YDRAFPISHIRFWAL | 66 | Q9Y6H8 | |
| LTEPPFRWRFYLHET | 26 | P60507 | |
| GIRRWNYFFPEELLV | 396 | Q96LW4 | |
| YVLSVLWDGLPRHFI | 491 | P07332 | |
| VHFYWVRGEEIIPRG | 206 | Q9NP92 | |
| WVPRKGLHLFAVFYT | 56 | O95562 | |
| GDLIEIFRPFYRHWA | 11 | P53816 | |
| IFRPFYRHWAIYVGD | 16 | P53816 | |
| GPYLGVHLRRKDFIW | 286 | Q9Y2G5 | |
| GNIFYLFEPLWHIER | 156 | Q7LGC8 | |
| APGFVYAWLELISHR | 2031 | A5YKK6 | |
| HPNLWIRYGAVGFIT | 666 | Q99570 | |
| RGHAAPILYAAWVEV | 76 | Q9H0I9 | |
| RGEVWPFLLRYYSHE | 431 | Q8TBP0 | |
| FGYEVWREFPDRLVG | 551 | Q93063 | |
| FGTIHVPYTRVWDFI | 56 | Q86V40 | |
| RDTHLWYFVIPGFSI | 286 | Q9H0V1 | |
| WQTHPFLRGIGYRIF | 1426 | Q86WI1 | |
| TEWRGPRVLYFGDHL | 346 | Q9H857 | |
| LFIWAIRHPASGYVQ | 306 | Q8WUA7 | |
| HNIYVWDVRRPFVPA | 276 | Q96S15 | |
| LWYHTVVRPFFALDG | 276 | Q8N584 | |
| DWHIAYVLLYGPRRV | 471 | P54578 | |
| LHSVWRLIPAFRGYA | 406 | Q9H0E7 | |
| YTEDEVLWGHRFFPV | 316 | P48549 | |
| RDAGFRVTLWVHPFV | 381 | Q6NSJ0 |